The latest market report published by Credence Research, Inc. “Global Cell Dissociation Market: Growth, Prospects, and Competitive Analysis, 2016 – 2030“. The global cell dissociation market generated revenue of around USD 518.6 billion in 2022 and is anticipated to grow a CAGR of over 18.20% during the forecast period from 2018 to 2030 to reach around USD 1671.7 billion in 2030.
The increasing demand for R&D in biopharmaceutical companies is anticipated to fuel the development of the cell dissociation market during the forecast period. Furthermore, the favourable funding climate for cancer research, as well as the rising incidence and prevalence of infectious and chronic diseases, are expected to drive the growth of the cell dissociation market. Furthermore, it is anticipated that the increasing focus on individualised care and the rise in government funding for cell-based research will impede the expansion of the cell dissociation market. In contrast, it is further anticipated that the timeline period will witness a slowdown in the growth of the cell dissociation market because of the rising cost of cell-based research and the absence of infrastructure for cell-based research in the advanced countries.
The global cell dissociation market is bifurcated into product type, tissue, dissociation, end user, and geography. Based on product type, the cell dissociation market is categorized into enzymatic dissociation products (collagenase, trypsin, papain, elastase, dnase, hyaluronidase, others) and instruments. Based on tissue, the global cell dissociation market is segmented into connective tissues, epithelial tissues and others. Based on dissociation, the market is categorized into tissue dissociation and cell detachment. Based on end user, the cell dissociation market is categorized into biotechnology companies, pharmaceutical companies, academic institutes and research institutes. Based on geography, the cell dissociation market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
In 2022, North America is expected to occupy the largest cell dissociation market share in revenue and sales because the prevalence of cancer and other chronic diseases is increasing. The emergence of significant important players and the rising industrial and academic interest in research and development in the bio sciences will both contribute to the region’s cell dissociation market’s expansion throughout the course of the projected year. Furthermore, funding is being provided to a number of local businesses to help them create a cure for a number of chronic illnesses, including cancer.
Cell Dissociation Market major players analysis is a crucial aspect of the biotechnology industry. The market consists of various manufacturers and suppliers, each offering their unique products and services to cater to the needs of researchers, scientists, and pharmaceutical organizations. Thermo Fisher Scientific, Merck KGaA, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, Worthington Biochemical Corporation are some of the key players in this market segment who have established themselves as leading providers of high-quality cell dissociation products. These companies offer an extensive range of enzymes such as trypsin and collagenase required for cell detachment from cultures or tissues.
The growth can be attributed to several factors, including:
- Increasing demand for cell-based therapies: The demand for cell-based therapies is increasing as these therapies become more widely used in the treatment of a range of diseases and conditions. Cell dissociation is a critical step in the process of isolating and growing cells for use in these therapies, which is driving the growth of the market.
- Advancements in cell dissociation technology: Advances in cell dissociation technology, such as the development of enzyme-free dissociation methods and the use of microfluidic devices, are driving the growth of the market. These new technologies offer improved efficiency, reduced cell stress, and higher yields, which is driving demand.
- Increasing research activities: The growing focus on research and development in the fields of biotechnology and regenerative medicine is driving the growth of the cell dissociation market. Researchers are using cell dissociation techniques to isolate and study different types of cells, which is driving demand for cell dissociation products.
- Rising prevalence of chronic diseases: The rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disease, is driving demand for cell-based therapies. Cell dissociation is a critical step in the production of these therapies, which is driving the growth of the market.
- Increasing funding for research and development: Governments and private organizations are investing heavily in research and development activities in the fields of biotechnology and regenerative medicine. This is driving demand for cell dissociation products, as researchers require high-quality dissociation products for their studies.
Why to Buy This Report-
- The report provides a qualitative and quantitative analysis of the global cell dissociation by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2018-2021, base year- 2022, and forecast period 2023-2030.
- The report contains information related to the competitive landscape, like how the key players in the market are operating at a global, regional, and country level.
- In-depth analysis of the global cell dissociation segmentation based on product type, tissue, dissociation, end user, and regional integration.
- The global cell dissociation report also includes analyzing the global, regional, and country levels, key market trends, significant players analysis, market growth strategies, and key application areas.
Browse Full Report: https://www.credenceresearch.com/report/cell-dissociation-market
Related Reports: https://www.credenceresearch.com/report/biomarkers-market